Want to see TSE:VIBE full AI Analyst Report?

Vibe Bioscience Ltd (VIBE) Price & Analysis

9 Followers

VIBE Stock Chart & Stats

C$0.06

C$0.00(0.00%)

At close: Jan 08 4:00 PM EST

C$0.06

C$0.00(0.00%)

Day’s Range― - ―

52-Week RangeC$0.30 - C$1.50

Previous CloseN/A

Volume81.00K

Average Volume (3M)6.19K

Market Cap

C$485.87K

Enterprise ValueC$1.78M

Total Cash (Recent Filing)C$909.58K

Total Debt (Recent Filing)C$2.38M

Price to Earnings (P/E)―

Beta3.08

Next Earnings

Aug 27, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-2.51

Shares Outstanding1,079,699

10 Day Avg. Volume10,465

30 Day Avg. Volume6,194

Financial Highlights & Ratios

PEG Ratio<0.01

Price to Book (P/B)>-0.01

Price to Sales (P/S)0.00224

P/FCF Ratio2.29

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Bulls Say, Bears Say

Bulls Say

Revenue Recovery & GrowthA ~497% TTM revenue rebound indicates renewed product-market traction and expanding customer adoption. Sustained top-line growth can spread fixed costs, improve operating leverage, and create a firmer base for reinvesting in R&D and commercialization over the next 2–6 months and beyond.

Improving Profitability & MarginsA roughly 43% gross margin with positive EBIT/EBITDA shows meaningful improvement in unit economics and operational execution. If maintained, these margins support sustainable cash generation, fund product development, and reduce dependency on external financing over the medium term.

Positive Operating & Free Cash FlowTurning operating and free cash flow positive reflects better cash conversion and working-capital management. Consistent positive cash flow reduces immediate refinancing pressure, helps fund near-term operations, and improves the company’s ability to invest selectively without dilutive capital raises.

Bears Say

Negative Shareholders' EquityNegative equity signals accumulated losses and a thin capital cushion, constraining strategic flexibility. It raises lender and counterparty concerns, can limit access to credit or require costly financing, and increases vulnerability to shocks or adverse cash-flow swings over the medium term.

Ongoing Net LossesA negative net margin of ~-14% means the company has yet to convert improved operating metrics into net profitability. Continued losses erode retained capital and may necessitate equity or debt raises, which can dilute shareholders or add leverage, limiting long-term strategic options.

Revenue Volatility HistoricallyThe historical pattern of revenue declines followed by a rebound indicates demand or execution variability. Such volatility complicates forecasting, capacity and inventory planning, and can produce uneven operating leverage, making sustained margin and cash-flow improvements less certain.

Vibe Bioscience Ltd News

Vibe Growth Director to Reduce Stake with Share Sale

Vibe Bioscience Ltd ( ($TSE:VIBE) ) has shared an update. Mark Waldron, a director at Vibe Growth Corporation,...

12M ago

Vibe Growth Plans Strategic Share Consolidation

Vibe Bioscience Ltd (TSE:VIBE) has released an update. Vibe Growth Corporation, a leading cannabis company, has announced a...

2y ago

VIBE

VIBE FAQ

What was Vibe Bioscience Ltd’s price range in the past 12 months?

Vibe Bioscience Ltd lowest stock price was C$0.30 and its highest was C$1.50 in the past 12 months.

What is Vibe Bioscience Ltd’s market cap?

Vibe Bioscience Ltd’s market cap is C$485.87K.

When is Vibe Bioscience Ltd’s upcoming earnings report date?

Vibe Bioscience Ltd’s upcoming earnings report date is Aug 27, 2026 which is in 57 days.

How were Vibe Bioscience Ltd’s earnings last quarter?

Currently, no data Available

Is Vibe Bioscience Ltd overvalued?

According to Wall Street analysts Vibe Bioscience Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Vibe Bioscience Ltd pay dividends?

Vibe Bioscience Ltd does not currently pay dividends.

What is Vibe Bioscience Ltd’s EPS estimate?

Vibe Bioscience Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Vibe Bioscience Ltd have?

Vibe Bioscience Ltd has 1,079,699 shares outstanding.

What happened to Vibe Bioscience Ltd’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Vibe Bioscience Ltd?

Currently, no hedge funds are holding shares in TSE:VIBE

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Vibe Bioscience Ltd

Vibe Growth Corp. is a vertically integrated cannabis company. The firm operates retail dispensaries, cannabis greenhouse and indoor cultivation, commercial distribution and transportation, e-commerce and home delivery, and manufacturing of marijuana products. It operates through the following segments: Dispensaries, Cultivation, Real Estate, and Canada. The company was founded on January 19, 2011 and is headquartered in Vancouver, Canada.